WallStSmart

Berkshire Hathaway Inc (BRK-B)vsOaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

BRK-B leads profitability with a 18.0% profit margin vs 0.0%. BRK-B trades at a lower P/E of 15.3x. BRK-B earns a higher WallStSmart Score of 54/100 (C-).

BRK-B

Buy

54

out of 100

Grade: C-

Growth: 3.3Profit: 7.5Value: 5.0Quality: 8.0
Piotroski: 3/9Altman Z: 2.60

OACC

Avoid

30

out of 100

Grade: F

Growth: 4.3Profit: 3.5Value: 4.7Quality: 5.8
Piotroski: 2/9

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BRK-B6 strengths · Avg: 9.2/10
Market CapQuality
$1.03T10/10

Mega-cap, among the largest globally

Price/BookValuation
0.0x10/10

Reasonable price relative to book value

Operating MarginProfitability
33.0%10/10

Strong operational efficiency at 33.0%

Debt/EquityHealth
0.199/10

Conservative balance sheet, low leverage

P/E RatioValuation
15.3x8/10

Attractively priced relative to earnings

Free Cash FlowQuality
$4.99B8/10

Generating 5.0B in free cash flow

OACC1 strengths · Avg: 10.0/10
Debt/EquityHealth
0.0010/10

Conservative balance sheet, low leverage

Areas to Watch

BRK-B4 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
10.062/10

Expensive relative to growth rate

Revenue GrowthGrowth
-0.7%2/10

Revenue declined 0.7%

EPS GrowthGrowth
-2.5%2/10

Earnings declined 2.5%

OACC4 concerns · Avg: 3.8/10
P/E RatioValuation
35.6x4/10

Premium valuation, high expectations priced in

Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$262.54M3/10

Smaller company, higher risk/reward

Comparative Analysis Report

WallStSmart Research

Bull Case : BRK-B

The strongest argument for BRK-B centers on Market Cap, Price/Book, Operating Margin. Profitability is solid with margins at 18.0% and operating margin at 33.0%.

Bull Case : OACC

The strongest argument for OACC centers on Debt/Equity.

Bear Case : BRK-B

The primary concerns for BRK-B are Piotroski F-Score, PEG Ratio, Revenue Growth.

Bear Case : OACC

The primary concerns for OACC are P/E Ratio, Revenue Growth, EPS Growth.

Key Dynamics to Monitor

BRK-B profiles as a declining stock while OACC is a value play — different risk/reward profiles.

OACC is growing revenue faster at 0.0% — sustainability is the question.

BRK-B generates stronger free cash flow (5.0B), providing more financial flexibility.

Monitor INSURANCE - DIVERSIFIED industry trends, competitive dynamics, and regulatory changes.

Bottom Line

BRK-B scores higher overall (54/100 vs 30/100), backed by strong 18.0% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Berkshire Hathaway Inc

FINANCIAL SERVICES · INSURANCE - DIVERSIFIED · USA

Berkshire Hathaway Inc. is an American multinational conglomerate holding company headquartered in Omaha, Nebraska, United States. The company wholly owns GEICO, Duracell, Dairy Queen, BNSF, Lubrizol, Fruit of the Loom, Helzberg Diamonds, Long & Foster, FlightSafety International, Pampered Chef, Forest River, and NetJets, and also owns 38.6% of Pilot Flying J; and significant minority holdings in public companies Kraft Heinz Company (26.7%), American Express (18.8%), The Coca-Cola Company (9.32%), Bank of America (11.9%), and Apple (6.3%).

Visit Website →

Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share

FINANCIAL SERVICES · SHELL COMPANIES · USA

Oaktree Acquisition Corp. III (OACC) is a special purpose acquisition company (SPAC) dedicated to merging with innovative firms in the life sciences sector. Led by a highly seasoned management team with deep expertise in healthcare investments, OACC seeks to capitalize on growth opportunities across diverse areas such as healthcare technology, therapeutics, and medical devices. The company prioritizes strategic partnerships and meticulous due diligence to maximize shareholder value, positioning itself for success in the dynamic and evolving landscape of life sciences.

Visit Website →

Want to dig deeper into these stocks?